Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care.

[1]  D. McCarty,et al.  Recurrent risk of hospitalization among older people with problematic alcohol use: a multiple failure‐time analysis with a discontinuous risk model , 2022, Addiction.

[2]  G. D’Onofrio,et al.  Use of a Brief Negotiation Interview in the emergency department to reduce high‐risk alcohol use among older adults: A randomized trial , 2022, Journal of the American College of Emergency Physicians open.

[3]  J. Holtrop,et al.  Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives. , 2021, Journal of substance abuse treatment.

[4]  B. Linas,et al.  Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study , 2021, The Lancet. Public health.

[5]  S. Nielsen,et al.  Time to address addiction treatment inequality in hospital settings. , 2021, The Lancet. Public health.

[6]  D. Basu,et al.  Predictors of Five-Year Readmission to an Inpatient Service among Patients with Alcohol Use Disorders: Report from a Low-Middle Income Country , 2021, Substance use & misuse.

[7]  I. Petersen,et al.  Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study , 2021, PLoS medicine.

[8]  M. Kushel,et al.  National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014–2018 , 2021, Journal of General Internal Medicine.

[9]  S. Calcaterra,et al.  The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap , 2021, Journal of General Internal Medicine.

[10]  X. Levander,et al.  Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis , 2021, Journal of addiction medicine.

[11]  K. O’grady,et al.  Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder , 2021, Annals of Internal Medicine.

[12]  J. Caulkins,et al.  Heroin Use Cannot Be Measured Adequately with a General Population Survey. , 2021, Addiction.

[13]  Likang Xu,et al.  Assessment of Annual Cost of Substance Use Disorder in US Hospitals , 2021, JAMA network open.

[14]  R. Martinez.  Challenges in the management of pain in hospital patients with opioid use disorder. , 2021, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[15]  A. Adejumo,et al.  Predictors, rates, and trends of opioid use disorder among patients hospitalized with chronic pancreatitis , 2021, Annals of gastroenterology.

[16]  Tran H. Tran,et al.  The substance use intervention team: A hospital-based intervention and outpatient clinic to improve care for patients with substance use disorders. , 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[17]  M. Choinière,et al.  “They think you’re trying to get the drug”: Qualitative investigation of chronic pain patients’ health care experiences during the opioid overdose epidemic in Canada , 2021, Canadian journal of pain = Revue canadienne de la douleur.

[18]  M. Mclean,et al.  Building a hospital-based addiction medicine consult service in Vancouver, Canada: the path taken and lessons learned. , 2020, Addiction.

[19]  T. Brothers,et al.  Implementation and evaluation of a novel, unofficial, trainee-organized hospital addiction medicine consultation service , 2020, Substance abuse.

[20]  S. Wakeman,et al.  A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation , 2020, Substance abuse.

[21]  R. Weiss,et al.  Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective Endocarditis , 2020, JAMA network open.

[22]  J. Singh,et al.  Trends in Hospitalizations for Alcohol Use Disorder in the US From 1998 to 2016. , 2020, JAMA network open.

[23]  O. Oladunjoye,et al.  Trends of Opioid Use Disorder and Associated Factors in Hospitalized Patients With Arthritis , 2020, Cureus.

[24]  Asher J Schranz,et al.  Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments. , 2020, Infectious disease clinics of North America.

[25]  Jared W Klein,et al.  Successful engagement in buprenorphine treatment among hospitalized patients with opioid use disorder and trauma. , 2020, Drug and alcohol dependence.

[26]  H. Englander,et al.  Patterns of substance use before and after hospitalization among patients seen by an inpatient addiction consult service: A latent transition analysis. , 2020, Journal of substance abuse treatment.

[27]  Mark E. Howard,et al.  Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[28]  S. Wakeman,et al.  Impact of Inpatient Addiction Consultation on Hospital Readmission , 2020, Journal of General Internal Medicine.

[29]  R. Reid,et al.  The Substance Treatment and Recovery Team (START): Measuring the effectiveness and feasibility of an inpatient addiction consult service at an academic general hospital. , 2020, General hospital psychiatry.

[30]  S. Wakeman,et al.  The Impact of Access to Addiction Specialist on Attitudes, Beliefs and Hospital-Based Opioid Use Disorder Related Care: A Survey of Hospitalist Physicians , 2020, Substance abuse.

[31]  B. Marshall,et al.  Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States , 2020, JAMA network open.

[32]  D. McCarty,et al.  "Now hospital leaders are paying attention": A qualitative study of internal and external factors influencing addiction consult services. , 2020, Journal of substance abuse treatment.

[33]  D. McCarty,et al.  Making the business case for an addiction medicine consult service: a qualitative analysis , 2019, BMC Health Services Research.

[34]  Michael Lawrence Barnett,et al.  Stigma as a fundamental hindrance to the United States opioid overdose crisis response , 2019, PLoS medicine.

[35]  Alison B. Hamilton,et al.  Qualitative methods in implementation research: An introduction , 2019, Psychiatry Research.

[36]  Ryan D. Ross,et al.  Buprenorphine Treatment Divide by Race/Ethnicity and Payment. , 2019, JAMA psychiatry.

[37]  T. Wilens,et al.  The Prevalence of Unhealthy Alcohol and Drug use among Inpatients in a General Hospital , 2019, Substance abuse.

[38]  Jacquelin Peck,et al.  Trends of Opioid Use Disorder Among Hospitalized Patients With Chronic Pain , 2019, Pain practice : the official journal of World Institute of Pain.

[39]  S. Baral,et al.  Development and reliability of metrics to characterize types and sources of stigma among men who have sex with men and female sex workers in Togo and Burkina Faso , 2019, BMC Infectious Diseases.

[40]  D. Warren,et al.  Addiction Medicine Consultations Reduce Readmission Rates for Patients With Serious Infections From Opioid Use Disorder. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  Bonnie K. Lind,et al.  Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis , 2019, Journal of General Internal Medicine.

[42]  S. Kenyon,et al.  Can rapid approaches to qualitative analysis deliver timely, valid findings to clinical leaders? A mixed methods study comparing rapid and thematic analysis , 2018, BMJ Open.

[43]  Na Wang,et al.  Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality , 2018, Annals of Internal Medicine.

[44]  Eyal Oren,et al.  The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States , 2018, JAMA.

[45]  M. Khan,et al.  Admissions for Infective Endocarditis in Intravenous Drug Users. , 2018, Journal of the American College of Cardiology.

[46]  D. Tompkins,et al.  The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use. , 2017, Drug and alcohol dependence.

[47]  J. Samet,et al.  Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. , 2017, Journal of substance abuse treatment.

[48]  N. Rigotti,et al.  Inpatient Addiction Consultation for Hospitalized Patients Increases Post-Discharge Abstinence and Reduces Addiction Severity , 2017, Journal of General Internal Medicine.

[49]  H. Englander,et al.  Planning and Designing the Improving Addiction Care Team (IMPACT) for Hospitalized Adults with Substance Use Disorder , 2017, Journal of hospital medicine.

[50]  I. Danovitch,et al.  Overcoming Barriers to Initiating Medication-assisted Treatment for Heroin Use Disorder in a General Medical Hospital: A Case Report and Narrative Literature Review , 2017, Journal of psychiatric practice.

[51]  S. Wakeman.  Medications For Addiction Treatment: Changing Language to Improve Care. , 2017, Journal of addiction medicine.

[52]  P. Korthuis,et al.  “It’s been an Experience, a Life Learning Experience”: A Qualitative Study of Hospitalized Patients with Substance Use Disorders , 2017, Journal of General Internal Medicine.

[53]  T. Mark,et al.  Post-Discharge Treatment Engagement Among Patients with an Opioid-Use Disorder. , 2016, Journal of substance abuse treatment.

[54]  K. Donelan,et al.  Attitudes, practices, and preparedness to care for patients with substance use disorder: Results from a survey of general internists , 2016, Substance abuse.

[55]  S. Herzig,et al.  Hospitalizations Related To Opioid Abuse/Dependence And Associated Serious Infections Increased Sharply, 2002-12. , 2016, Health affairs.

[56]  B. Druss,et al.  Unpacking Collaborative Care for Depression: Examining Two Essential Tasks for Implementation. , 2016, Psychiatric services.

[57]  M. Ilgen,et al.  Revisiting our review of Screening, Brief Intervention and Referral to Treatment (SBIRT): meta-analytical results still point to no efficacy in increasing the use of substance use disorder services. , 2016, Addiction.

[58]  H. Baumeister,et al.  Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials , 2015, BMJ Open.

[59]  G. D’Onofrio,et al.  Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. , 2015, JAMA.

[60]  J. Tulsky,et al.  An Inpatient Treatment and Discharge Planning Protocol for Alcohol Dependence: Efficacy in Reducing 30-Day Readmissions and Emergency Department Visits , 2015, Journal of General Internal Medicine.

[61]  B. Anderson,et al.  Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. , 2014, JAMA internal medicine.

[62]  M. Tadesse,et al.  Assessing validity of a depression screening instrument in the absence of a gold standard. , 2014, Annals of epidemiology.

[63]  Sofie Mauger,et al.  Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence , 2014, Neuropsychiatric disease and treatment.

[64]  W. Katon,et al.  Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee. , 2014, Psychosomatics.

[65]  C. Chaisson,et al.  Patient perspectives of an integrated program of medical care and substance use treatment. , 2014, AIDS patient care and STDs.

[66]  J. Rotrosen,et al.  Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy , 2014, Addiction Science & Clinical Practice.

[67]  P. Skorga,et al.  Collaborative care for depression and anxiety problems , 2013 .

[68]  R. Chen,et al.  Collaborative care for patients with depression and diabetes mellitus: a systematic review and meta-analysis , 2013, BMC Psychiatry.

[69]  Y. Balhara.  Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines. , 2013, Journal of opioid management.

[70]  S. Stewart,et al.  Care for hospitalized patients with unhealthy alcohol use: a narrative review , 2013, Addiction Science & Clinical Practice.

[71]  S. Hayes,et al.  Self-Stigma in Substance Abuse: Development of a New Measure , 2013, Journal of psychopathology and behavioral assessment.

[72]  D. N. Bertollo,et al.  Variation in Use of Buprenorphine and Methadone Treatment by Racial, Ethnic, and Income Characteristics of Residential Social Areas in New York City , 2013, The Journal of Behavioral Health Services & Research.

[73]  G. Woody,et al.  Early data from project engage: a program to identify and transition medically hospitalized patients into addictions treatment , 2012, Addiction Science & Clinical Practice.

[74]  J. Probst,et al.  Missing the handoff: post-hospitalization follow-up care among rural Medicare beneficiaries with diabetes. , 2012, Rural and remote health.

[75]  Bruce R. Schackman,et al.  Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care , 2012, Journal of General Internal Medicine.

[76]  W. Becker,et al.  A Case Series of Buprenorphine/Naloxone Treatment in a Primary Care Practice , 2011, Substance abuse.

[77]  J. García-Campayo,et al.  Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. , 2011, Journal of affective disorders.

[78]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[79]  M. Taljaard,et al.  The independent association of provider and information continuity on outcomes after hospital discharge: implications for hospitalists. , 2010, Journal of hospital medicine.

[80]  K. Wells,et al.  Collaborative depression care: history, evolution and ways to enhance dissemination and sustainability. , 2010, General hospital psychiatry.

[81]  Peter R. Orszag,et al.  Health care reform and cost control. , 2010, The New England journal of medicine.

[82]  James G. Scott,et al.  The horseshoe estimator for sparse signals , 2010 .

[83]  S. Davis,et al.  Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. , 2010, American Journal of Preventive Medicine.

[84]  Harlan M Krumholz,et al.  Is Same-Hospital Readmission Rate a Good Surrogate for All-Hospital Readmission Rate? , 2010, Medical care.

[85]  M. Gourevitch,et al.  Substance use treatment barriers for patients with frequent hospital admissions. , 2010, Journal of substance abuse treatment.

[86]  D. Bell,et al.  A multi-centre survey of inpatient pharmacological management strategies for alcohol withdrawal. , 2009, QJM : monthly journal of the Association of Physicians.

[87]  S. Asch,et al.  Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference , 2009, Journal of general internal medicine.

[88]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[89]  Stephen A. Martin,et al.  A Reengineered Hospital Discharge Program to Decrease Rehospitalization , 2009, Annals of Internal Medicine.

[90]  M. Farrell,et al.  Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). , 2008, Addiction.

[91]  B. Löwe,et al.  Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population , 2008, Medical care.

[92]  R. Spitzer,et al.  The PHQ-9 , 2001, Journal of General Internal Medicine.

[93]  C. Cook,et al.  Inpatient to outpatient transfer of diabetes care: perceptions of barriers to postdischarge followup in urban African American patients. , 2007, Ethnicity & disease.

[94]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[95]  B. Rounsaville,et al.  A Stage Model of Behavioral Therapies Research: Getting Started and Moving on From Stage I , 2006 .

[96]  G. D’Onofrio,et al.  Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[97]  K. A. Blanchard,et al.  Assessing consequences of substance use: psychometric properties of the inventory of drug use consequences. , 2003, Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors.

[98]  K. Seppä,et al.  Six-month outcomes of hospital-based psychiatric substance use consultations. , 2003, General hospital psychiatry.

[99]  S. Powell,et al.  Psychometric characteristics of the Multidimensional Scale of Perceived Social Support. , 1990, Journal of personality assessment.

[100]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.